Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017

This cross-sectional study uses data from the Centers for Medicare & Medicaid Services to assess the use of professional society guideline-nonconcordant radiotherapy in patients at the end of life.

Detalles Bibliográficos
Autores principales: Santos, Patricia Mae G., Mathis, Noah J., Lapen, Kaitlyn, Lobaugh, Stephanie, Yerramilli, Divya, Bekelman, Justin E., Gillespie, Erin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903107/
https://www.ncbi.nlm.nih.gov/pubmed/35977234
http://dx.doi.org/10.1001/jamahealthforum.2021.4468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903107/
https://www.ncbi.nlm.nih.gov/pubmed/35977234
http://dx.doi.org/10.1001/jamahealthforum.2021.4468

Ejemplares similares